|
π
|
Initial genome sequencing and analysis of multiple myeloma
49 auth.
M. Chapman,
M. Lawrence,
J. Keats,
K. Cibulskis,
C. Sougnez,
Anna C. Schinzel,
C. Harview,
Jean-Philippe Brunet,
G. Ahmann,
Mazhar Adli,
K. Anderson,
K. Ardlie,
D. Auclair,
A. Baker,
P. Bergsagel,
...
B. Bernstein,
Y. Drier,
R. Fonseca,
S. Gabriel,
C. Hofmeister,
S. Jagannath,
A. Jakubowiak,
A. Krishnan,
J. Levy,
T. Liefeld,
S. Lonial,
Scott Mahan,
Bunmi Mfuko,
S. Monti,
L. Perkins,
R. Onofrio,
Trevor J Pugh,
S. Vincent Rajkumar,
A. Ramos,
D. Siegel,
A. Sivachenko,
S. Trudel,
R. Vij,
Douglas Voet,
W. Winckler,
T. Zimmerman,
J. Carpten,
Jeff Trent,
W. Hahn,
L. Garraway,
M. Meyerson,
E. Lander,
G. Getz,
T. Golub
|
10 |
2011 |
10
π
|
|
π
|
Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.
30 auth.
J. Keats,
R. Fonseca,
M. Chesi,
R. Schop,
A. Baker,
W. Chng,
S. V. Van Wier,
R. Tiedemann,
C. Shi,
M. Sebag,
E. Braggio,
T. Henry,
Yuan-Xiao Zhu,
Homer Fogle,
T. Price-Troska,
...
G. Ahmann,
Catherine M. Mancini,
L. Brents,
Shaji K. Kumar,
P. Greipp,
A. Dispenzieri,
B. Bryant,
G. Mulligan,
L. Bruhn,
M. Barrett,
R. Valdez,
Jeff Trent,
A. Stewart,
J. Carpten,
P. Bergsagel
|
10 |
2007 |
10
π
|
|
π
|
Antitumor Activity of Rapamycin in a Phase I Trial for Patients with Recurrent PTEN-Deficient Glioblastoma
23 auth.
T. Cloughesy,
K. Yoshimoto,
P. Nghiemphu,
K. Brown,
Julie H T Dang,
Shaojun Zhu,
Teli Hsueh,
Yinan Chen,
Wei Wang,
D. Youngkin,
...
L. Liau,
N. Martin,
Donald P. Becker,
M. Bergsneider,
A. Lai,
R. Green,
Tom Oglesby,
Michael Koleto,
Jeff Trent,
S. Horvath,
P. Mischel,
I. Mellinghoff,
C. Sawyers
|
9 |
2008 |
9
π
|
|
π
|
APC binds to the novel protein EB1.
9 auth.
L. Su,
M. Burrell,
D. Hill,
JenΓ ΒΆ Gyuris,
R. Brent,
R. Wiltshire,
...
Jeff Trent,
B. Vogelstein,
K. Kinzler
|
8 |
1995 |
8
π
|
|
π
|
Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial
27 auth.
N. Dizman,
L. Meza,
P. Bergerot,
Marice B. Alcantara,
T. Dorff,
Y. Lyou,
P. Frankel,
Yujie Cui,
Valerie Mira,
M. Llamas,
J. Hsu,
Z. Zengin,
N. Salgia,
S. Salgia,
J. Malhotra,
...
N. Chawla,
A. Chehrazi-Raffle,
R. Muddasani,
J. Gillece,
L. Reining,
Jeff Trent,
Motomichi Takahashi,
K. Oka,
S. Higashi,
M. Kortylewski,
S. Highlander,
S. Pal
|
8 |
2022 |
8
π
|
|
π
|
Targeting Human Cancer by a Glycosaminoglycan Binding Malaria Protein.
35 auth.
A. Salanti,
T. M. Clausen,
Mette Γ. AgerbΓ¦k,
N. Al Nakouzi,
M. DahlbaΜck,
H. Oo,
Sherry Lee,
T. Gustavsson,
J. Rich,
B. Hedberg,
Yang Mao,
Line Barington,
M. A. Pereira,
J. LoBello,
M. Endo,
...
L. Fazli,
J. Soden,
C. Wang,
A. Sander,
R. Dagil,
S. Thrane,
P. Holst,
Le Meng,
F. Favero,
G. Weiss,
M. Nielsen,
Jim Freeth,
T. Nielsen,
J. Zaia,
N. Tran,
Jeff Trent,
J. Babcook,
T. Theander,
P. Sorensen,
M. Daugaard
|
7 |
2015 |
7
π
|
|
π
|
Direct cloning of human neuroblastoma cells in soft agar culture.
8 auth.
D. D. Hoff,
J. Casper,
E. Bradley,
Jeff Trent,
A. Hodach,
C. Reichert,
...
R. Makuch,
A. Altman
|
6 |
1980 |
6
π
|
|
π
|
Establishing community reference samples, data and call sets for benchmarking cancer mutation detection using whole-genome sequencing
79 auth.
Li Tai Fang,
B. Zhu,
Yongmei Zhao,
Wanqiu Chen,
Zhaowei Yang,
L. Kerrigan,
K. Langenbach,
M. de Mars,
Charles Lu,
K. Idler,
H. Jacob,
Yuanting Zheng,
Luyao Ren,
Ying Yu,
Erich Jaeger,
...
G. Schroth,
O. Abaan,
Keyur Talsania,
J. Lack,
Tsai-wei Shen,
Zhong Chen,
Seta Stanbouly,
Bao Tran,
Jyoti Shetty,
Yuliya Kriga,
D. Meerzaman,
Cu Nguyen,
Virginie Petitjean,
M. Sultan,
M. Cam,
M. Mehta,
T. Hung,
E. Peters,
R. Kalamegham,
S. M. Sahraeian,
M. Mohiyuddin,
Yunfei Guo,
Lijing Yao,
L. Song,
Hugo Y. K. Lam,
J. DrΓ‘bek,
P. Vojta,
R. Maestro,
D. Gasparotto,
S. KΓ΅ks,
E. Reimann,
A. Scherer,
J. Nordlund,
U. Liljedahl,
R. Jensen,
M. Pirooznia,
Zhipan Li,
Chunlin Xiao,
S. Sherry,
R. Kusko,
Malcolm Moos,
Eric F. Donaldson,
Z. Tezak,
B. Ning,
W. Tong,
Jing Li,
Penelope Duerken-Hughes,
C. Catalanotti,
S. Maheshwari,
Joe Shuga,
Winnie S. Liang,
J. Keats,
J. Adkins,
Erica E Tassone,
V. Zismann,
T. McDaniel,
Jeff Trent,
J. Foox,
D. Butler,
C. Mason,
H. Hong,
Leming Shi,
Charles Wang,
Wenming Xiao
|
5 |
2021 |
5
π
|
|
π’
|
Opportunities and Barriers in the Age of Team Science: Strategies for Success
T. Sellers,
N. Caporaso,
S. Lapidus,
G. Petersen,
Jeff Trent
|
4 |
2006 |
4
π’
|
|
π
|
Promiscuous Mutations Frequently Activate the Non-Canonical NFkB Pathway in Multiple Myeloma (MM).
24 auth.
P. Bergsagel,
J. Carpten,
M. Chesi,
S. Vanwier,
J. Keats,
M. Sebag,
W. Chng,
R. Schop,
A. Baker,
Tae-Hoon Chng,
...
Homer Fogle,
Yuan-Xiao Zhu,
C. Shi,
L. Bruhn,
M. Barrett,
Catherine M. Mancini,
T. Price-Troska,
G. Ahmann,
K. Henderson,
P. Greipp,
A. Dispenzieri,
Jeff Trent,
K. Stewart,
R. Fonseca
|
2 |
2006 |
2
π
|
|
π
|
The value of comprehensive genomic sequencing to maximize the identification of clinically actionable alterations in advanced cancer patients: a case series
11 auth.
Kevin Drenner,
G. Basu,
L. Goodman,
A. Ozols,
J. LoBello,
Thomas E. Royce,
...
M. Gordon,
E. Borazanci,
Margaux A. Steinbach,
Jeff Trent,
Sunil Sharma
|
1 |
2021 |
1
π
|
|
π
|
APC Binds to the Novel Protein EB11
12 auth.
L. Su,
Marilee,
Burrell,
D. Hill,
JenΓ ΒΆ Gyuris,
R. Brent,
...
Rodney,
Wiltshire,
Jeff Trent,
B. Vogelstein,
Kenneth,
W. Kinzler
|
0 |
2021 |
0
π
|
